levodopa has been researched along with CADASILM in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berbellini, A; Cacchiò, G; De Michele, G; De Rosa, A; Di Marzio, F; Manca, A; Pianese, L; Ragno, M; Scarcella, M; Silvestri, S | 1 |
| Brigo, F; Golaszewski, S; Höller, Y; Kunz, AB; Lochner, P; Nardone, R; Thomschewski, A; Trinka, E | 1 |
2 other study(ies) available for levodopa and CADASILM
| Article | Year |
|---|---|
Parkinsonism is a late, not rare, feature of CADASIL: a study on Italian patients carrying the R1006C mutation.
Topics: Aged; Brain; CADASIL; Exons; Female; Genetic Predisposition to Disease; Humans; Italy; Leukoencephalopathies; Levodopa; Magnetic Resonance Imaging; Male; Mutation; Parkinsonian Disorders; Receptor, Notch3; Receptors, Notch; Tomography, Emission-Computed, Single-Photon | 2013 |
Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.
Topics: Acetylcholine; Afferent Pathways; Aged; Alzheimer Disease; Brain; CADASIL; Dopamine; Dopamine Agents; Evoked Potentials, Motor; Humans; Levodopa; Neural Inhibition; Transcranial Magnetic Stimulation | 2014 |